Slope

EDC systems and paper-based requisition forms have long been the standard for capturing sample metadata at the site and sharing that data with sponsors, labs, and CROs. This week on the blog, we break down how this process may be introducing risk into your trials and what other solutions exist to capture this essential data. #samplemanagement #clinicaltrials #clinicalresearch #biopsecimens #samplemetadata

Interested in improving your biosample oversight, optimizing sampling compliance, and accelerating study milestones? Join us tomorrow from 12:00–12:30pm EST for this product demo! We'll showcase how using our platform could be the key to overcoming common sampling compliance issues. Register Here: https://hubs.la/Q02DrJCT0

Thank you to Fierce Biotech for sharing the news about the formation of the Biospecimen Management Consortium (BMC). To learn more about the BMC and read the perspectives of some of our founding members, click below! #BiospecimenConsortium #BiospecimenManagement #ClinicalTrials

If you've worked in #clinicalresearch long enough, you're likely familiar with the distressing feeling of not knowing where a sample is or why it hasn't been analyzed yet. The lengthy — and often manual — process of tracking down that sample can leave you wondering why there isn't an easier way. This week on the blog, we delve into the roots of this issue and explore the consequences of having a chaotic #samplemanagement process. #datareconciliation #sampletracking #biospecimenmanagement #clinicaltrials

Slope is honored to host the Biospecimen Management Consortium (BMC) an industry-led consortium with the shared objective of driving sample excellence in clinical research. Founding members include GRAIL, GSK, ILiAD Biotechnologies, LLC, Moderna, Novartis, Roche, Takeda, and Teal Health. We commend these organizations for joining together to set standards, streamline operations and data, and shape regulatory policy. To read the full press release, view here: https://lnkd.in/gKxTBBRp #BiospecimenConsortium #BiospecimenManagement #ClinicalTrials

Day one of the AACI (Association of American Cancer Institutes) CRI meeting has been flying by! There's still time to stop by our booth on the exhibit floor today to see how we can help streamline your site operations and find out why we're trusted by more than 75% of NCI-designated cancer centers. #siteinnovation #siteoperations #clinicalresearch #clinicaltrials

Are your clinical quality audits revealing compliance issues due to sample collection challenges, inadequate tracking, or complex shipping logistics that delay your study milestones? Join us next Thursday at 12 pm EST for this 30-minute product demonstration where we showcase how the Slope platform could be the key to tackling these challenges in your trials. #clinicaltrials #clinicalresearch #samplemangement #compliance #datareconciliation

In our newest blog, we uncover the limitations of traditional paper-based requisition forms and explore how digitizing these processes can reduce data reconciliation needs. Read more below to learn how electronic requisitions can enhance data accuracy, save time, and improve the overall management of sample metadata in your trials. #datareconciliation #samplemetadata #clinicaltrials #clinicalresearch

As we announced last month, our nationwide SELF-CERV study completed enrollment ahead of schedule, while exceeding initial enrollment projections. This was made possible because of the exceptional teams at our study sites and the amazing women who raised their hands to participate. Additionally, we had great partners, like Slope to ensure the operations and logistics ran smoothly. Our very own Trena Depel recently participated in Slope Clinical’s Advisory meeting to discuss the value that using Slope’s biospecimen sample management platform brought to our study. Slope is dedicated to driving best practices in biospecimen management and was an invaluable partner to the rapid and successful enrollment of SELF-CERV, with over 1,000 samples to manage. Our clinical sites loved the simplicity of ordering supplies, logging samples, and managing shipments using the Slope platform, and Teal Health appreciated the real-time metrics to understand enrollment and sample movement across our 17 clinical sites and multiple labs. We will certainly be using Slope for our future studies as well. Here are a few highlights of the benefits we measured.

The real danger when encountering an iceberg isn't what can be seen from above the water, but rather what lurks below. Similarly, in clinical trials, the most significant risks are often those that remain unseen — especially when we're discussing sample management. Without comprehensive visibility into the sample management processes performed at sites, sponsors are left in the dark, vulnerable to a potential issues like compromised sample integrity, data inconsistencies, increased costs, and more. Learn which sample management activities you should be keeping an eye on to mitigate these issues and protect study outcomes in our newest blog. #samplemanagement #clinicaltrial #clinicalresearch